We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$254B
AUM Growth
+$235B
Cap. Flow
+$230B
Cap. Flow %
90.52%
Top 10 Hldgs %
17.14%
Holding
3,268
New
2,228
Increased
916
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.24B
2
AAPL icon
Apple
AAPL
+$6.76B
3
AMZN icon
Amazon
AMZN
+$6.52B
4
META icon
Meta Platforms (Facebook)
META
+$4.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.45B

Sector Composition

Rank Sector Weight
1 Technology 18.97%
2 Financials 14.46%
3 Healthcare 12.78%
4 Consumer Discretionary 10.65%
5 Industrials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSEX icon
2101
Middlesex Water
MSEX
$1.09B
$4.02M ﹤0.01%
+67,852
New +$3.94M
ATRA icon
2102
Atara Biotherapeutics
ATRA
$76.6M
$4.01M ﹤0.01%
+7,968
New +$5.62M
DRNA
2103
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3.99M ﹤0.01%
+253,556
New +$3.45M
VTLE
2104
DELISTED
Vital Energy
VTLE
$3.98M ﹤0.01%
+68,674
New +$4.16M
MATV icon
2105
Mativ Holdings
MATV
$696M
$3.97M ﹤0.01%
+119,764
New +$4.05M
AIMT
2106
DELISTED
Aimmune Therapeutics
AIMT
$3.97M ﹤0.01%
+190,655
New +$3.92M
EPZM
2107
DELISTED
Epizyme, Inc
EPZM
$3.96M ﹤0.01%
+315,561
New +$4.06M
NPKI
2108
NPK International
NPKI
$1.15B
$3.96M ﹤0.01%
+533,511
New +$4.12M
NFBK
2109
DELISTED
Northfield Bancorp
NFBK
$3.95M ﹤0.01%
+253,149
New +$3.78M
UEIC icon
2110
Universal Electronics
UEIC
$67M
$3.95M ﹤0.01%
+96,261
New +$3.85M
FSP
2111
Franklin Street Properties
FSP
$45.5M
$3.94M ﹤0.01%
+534,029
New +$4.05M
TSC
2112
DELISTED
TriState Capital Holdings, Inc.
TSC
$3.94M ﹤0.01%
+184,578
New +$4.04M
AMR icon
2113
Alpha Metallurgical Resources
AMR
$1.93B
$3.94M ﹤0.01%
+75,842
New +$4.21M
ACCO icon
2114
Acco Brands
ACCO
$400M
$3.92M ﹤0.01%
+498,717
New +$4.09M
IQ icon
2115
iQIYI
IQ
$1.34B
$3.92M ﹤0.01%
+190,000
New +$3.93M
PGNX
2116
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3.92M ﹤0.01%
+635,015
New +$3.06M
TISI icon
2117
Team
TISI
$76.3M
$3.92M ﹤0.01%
+25,554
New +$4.12M
FIT
2118
DELISTED
Fitbit, Inc. Class A common stock
FIT
$3.9M ﹤0.01%
+886,961
New +$4.47M
CPLG
2119
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$3.9M ﹤0.01%
+314,825
New +$3.99M
WPG
2120
DELISTED
Washington Prime Group Inc.
WPG
$3.89M ﹤0.01%
113,236
+111,135
+5,290% +$4.56M
SIG icon
2121
Signet Jewelers
SIG
$3.67B
$3.89M ﹤0.01%
+217,344
New +$4.67M
ONDK
2122
DELISTED
On Deck Capital, Inc.
ONDK
$3.89M ﹤0.01%
+936,354
New +$4.42M
NGVC icon
2123
Vitamin Cottage Natural Grocers
NGVC
$636M
$3.88M ﹤0.01%
+386,554
New +$4.43M
LNN icon
2124
Lindsay Corp
LNN
$1.16B
$3.86M ﹤0.01%
+46,921
New +$3.93M
UPWK icon
2125
Upwork
UPWK
$1.2B
$3.85M ﹤0.01%
+239,572
New +$4.13M

Similar funds

Nuveen's Q2 2019 Portfolio in Review

As of Q2 2019, Nuveen held 3,268 positions worth $254B, up 1,256% from $18.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nuveen deployed $230B of net new capital in Q2 2019, opening 2,228 new positions and adding to 916 existing holdings. Its largest new stake was Netflix: 33,941,080 shares worth $1.25B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $142M trimmed.

  • Nuveen's largest Q2 2019 buy was Netflix: 33,941,080 shares worth $1.25B.
  • Nuveen added most to Microsoft in Q2 2019, an estimated $8.24B increase.
  • Nuveen's biggest Q2 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $142M.
  • Nuveen fully exited Nuveen ESG Large-Cap Value ETF in Q2 2019, selling an estimated $22M.
  • Nuveen's ten largest holdings make up 17% of its $254B portfolio in Q2 2019.
  • Nuveen opened 2,228 new positions and closed 11 in Q2 2019.
  • Nuveen's portfolio value rose 1,256% quarter-over-quarter to $254B.

Based on Nuveen's 13F filing for Q2 2019, filed 15 Aug 2019.